Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on Nutrition and autoimmune disease Nutrition in Crohn's disease

Proceedings of the Nutrition Society

Volumn 68, Issue 2, 2009, Pages 127-134

  O'Sullivan, Maria ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Crohn's disease; Diet and disease risk; Nutritional status; Nutritional therapy; Vitamin D

Indexed keywords

CORTICOSTEROID; VITAMIN D;

AUTOIMMUNE DISEASE; CHILD; CONFERENCE PAPER; CROHN DISEASE; ENTERIC FEEDING; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MALNUTRITION; MEDICAL SOCIETY; MORTALITY; NUTRITION; NUTRITIONAL STATUS; OBESITY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADULT; BODY MASS; BODY WEIGHT; DIET; DIETETICS; IRELAND; PHYSIOLOGY; REVIEW; RISK FACTOR;

ADRENAL CORTEX HORMONES; ADULT; AUTOIMMUNE DISEASES; BODY MASS INDEX; BODY WEIGHT; CHILD; CROHN DISEASE; DIET; DIETETICS; ENTERAL NUTRITION; HUMANS; IRELAND; MALNUTRITION; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RISK FACTORS; SOCIETIES, MEDICAL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 67849127724     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665109001025     Document Type: Conference Paper

References (77)

1. Crohn B, Ginzburg L & Oppenheimer G (1932) Regional ileitis, a pathologic and clinical entity. JAMA 99, 1323-1329.
2. Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517.
3. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12, Suppl. 1, S3-S9.
4. Ogura Y, Bonen DK, Inohara N et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
5. Hugot J-P, Chamaillard M, Zouali H et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
6. Birrenbach T & Bocker U (2004) Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10, 848-859.
7. Mahmud N & Weir DG (2001) The urban diet and Crohn's disease: is there a relationship? Eur J Gastroenterol Hepatol 13, 93-95.
8. Shoda R, Matsueda K, Yamato S et al. (1996) Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 63, 741-745.
9. Mayberry JF, Rhodes J, Allan R et al. (1981) Diet in Crohn's disease. Two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 26, 444-448.
10. Martini GA & Brandes JW (1976) Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 54, 367-371.
11. Russel M, Engels L, Muris J et al. (1998) Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 10, 235-237.
12. Riordan AM, Ruxton CH & Hunter JO (1998) A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 52, 229-238.
13. MacLean CH, Mojica WA, Newberry SJ et al. (2005) Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 82, 611-619.
14. Sakamoto N, Kono S, Wakai K et al. (2005) Dietary risk factors for inflammatory bowel disease: a multicenter casecontrol study in Japan. Inflamm Bowel Dis 11, 154-163.
15. Amre DK, D'Souza S, Morgan K et al. (2007) Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 102, 2016-2025.
16. Filippi J, Al-Jaouni R, Wiroth J et al. (2006) Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis 12, 185-191.
17. Johtatsu T, Andoh A, Kurihara M et al. (2007) Serum concentrations of trace elements in patients with Crohn's disease receiving enteral nutrition. J Clin Biochem Nutr 41, 197-201.
18. Gasche C, Berstad A, Befrits R et al. (2007) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Inflamm Bowel Dis 13, 1545-1553.
19. Scott E, Gaywood I & Scott B (2000) Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 46, 1-8.
20. Bernstein C & Leslie W (2004) Osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther 19, 941-952.
21. Pirlich M, Schutz T, Kemps M et al. (2003) Prevalence of malnutrition in hospitalized medical patients: impact of underlying disease. Dig Dis 21, 245-251.
22. Nguyen GC, Munsell M & Harris ML (2008) Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 14, 1105-1111.
23. McWhirter J & Pennington C (1994) Incidence and recognition of malnutrition in hospital. Br Med J 308, 945-948. (Pubitemid 24111914)
24. Geerling BJ, Badart-Smook A, Stockbrugger RW et al. (1998) Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67, 919-926.
25. Jahnsen J, Falch J, Mowinckel P et al. (2003) Body composition in patients with inflammatory bowel disease: a population- based study. Am J Gastroenterol 98, 1556-1562.
26. Valentini L, Schaper L, Buning C et al. (2008) Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition 24, 694-702.
27. Nic Suibhne T, O'Morain C & O'Sullivan M (2006) Reduced muscle function and muscle stores are common in quiescent Crohn's disease. Gastroenterology 130, Suppl. 2, A-611.
28. Kugathasan S, Nebel J, Skelton JA et al. (2007) Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 151, 523-527.
29. Sokol J (2007) A new larger look to inflammatory bowel disease J Pediatr 51, 2A.
30. Sousa Guerreiro C, Cravo M, Costa AR et al. (2007) A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol 102, 2551-2556.
31. Blain A, Cattan S, Beaugerie L et al. (2002) Crohn's disease clinical course and severity in obese patients. Clin Nutr 21, 51-57.
32. Hass DJ, Brensinger CM, Lewis JD et al. (2006) The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 4, 482-488.
33. Schaffler A, Scholmerich J & Buchler C (2005) Mechanisms of disease: adipocytokines and visceral adipose tissue - emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2, 103-111. (Pubitemid 40790157)
34. Siffledeen J, Siminoski K, Steinhart H et al. (2003) The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 17, 473-478.
35. Tajika M, Matsuura A, Nakamura T et al. (2004) Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 39, 527-533.
36. Lanham-New SA (2008) Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment. Proc Nutr Soc 67, 163-176.
37. Bernstein CN, Leslie WD & Leboff MS (2003) American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124, 791-794.
38. McCarthy D, Duggan P, O'Brien M et al. (2005) Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 21, 1073-1083.
39. Lips P (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90, 611-614.
40. Heaney R (2004) Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 80, 1706S-1709S.
41. Vieth R & Carter G (2001) Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur J Clin Nutr 55, 221-222.
42. Hypponen E & Power C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85, 860-868.
43. Cantorna MT, Munsick C, Bemiss C et al. (2000) 1,25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130, 2648-2652.
44. Zhu Y, Mahon BD, Froicu M & Cantorna MT (2005) Calcium and 1a,25-dihydroxyvitamin D3 target the TNF-a pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35, 217-224.
45. Bartels LE, Jorgensen SP, Agnholt J et al. (2007) 1,25- dihydroxyvitamin D3 and dexamethasone increase interleukin- 10 production in CD4 + T cells from patients with Crohn's disease. Int Immunopharmacol 7, 1755-1764.
46. McCarthy D, Collins A, O'Brien M et al. (2006) Vitamin D intake and status in Irish elderly women and adolescent girls. Ir J Med Sci 175, 14-20.
47. Hill T, O'Brien M, Lamberg-Allardt C et al. (2006) Vitamin D status of 51-75-year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr 9, 225-233.
48. Chapuy MC, Preziosi P, Maamer M et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7, 439-443.
49. O'Sullivan M, Nic Suibhne T, Cox G et al. (2008) High prevalence of vitamin D insufficiency in healthy Irish adults. Ir J Med Sci 177, 131-134.
50. Voitk AJ, Echave V, Feller JH et al. (1973) Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg 107, 329-333.
51. Fisher J, Foster G, Abel R et al. (1973) Hyperalimentation as primary therapy for inflammatory bowel disease. Am J Surg 125, 165-175.
52. O'Morain C, Segal A & Levi A (1984) Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J 288, 1859-1862.
53. Sanderson IR, Udeen S, Davies PSW et al. (1987) Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 61, 123-127.
54. Royall D, Jeejeebhoy KN, Baker J et al. (1994) Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 35, 783-787.
55. Giaffer MH, North G & Holdsworth CD (1990) Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet 335, 816-819.
56. O'Sullivan M & O'Morain C (2001) Nutritional treatments in inflammatory bowel disease. Curr Treat Options Gastroenterol 4, 207-213.
57. O'Sullivan M & O'Morain C (2004) Nutritional therapy in inflammatory bowel disease. Curr Treat Options Gastroenterol 7, 191-198.
58. Teahon K, Pearson M, Levi AJ et al. (1995) Practical aspects of enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr 19, 365-368.
59. Fernandez-Banares F, Cabre E, Esteve-Comas M et al. (1995) How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 19, 356-364.
60. Messori A, Trallori G, D'Albasio G et al. (1996) Definedformula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 31, 267-272.
61. Zachos M, Tondeur M & Griffiths AM (2001) Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database of Systematic Reviews 2001, issue 3, CD000542. Chichester, West Sussex: John Wiley and Sons Ltd.
62. Carter MJ, Lobo AJ & Travis SPL (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53, Suppl. V, v1-v16.
63. Gassull MA (2004) Review article: the role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 20, 79-83.
64. Matsui T, Sakurai T & Yao T (2005) Nutritional therapy for Crohn's disease in Japan. J Gastroenterol 40, 25-31.
65. Rutgeerts P, Van Assche G & Vermeire S (2006) Infliximab therapy for inflammatory bowel disease - seven years on. Aliment Pharmacol Ther 23, 451-463.
66. Dziechciarz P, Horvath A, Shamir R et al. (2007) Metaanalysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 26, 795-806.
67. Day AS, Whitten KE, Sidler M et al. (2008) Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 27, 293-307.
68. Newby E, Sawczenko A, Thomas A et al. (2005) Interventions for growth failure in childhood Crohn's disease. Cochrane Database of Systemic Reviews 2005, issue 3, CD003873. Chichester, West Sussex: John Wiley & Sons Ltd.
69. Knight C, El-Matary W, Spray C et al. (2005) Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr 24, 775-779.
70. Wilschanski M, Sherman P, Pencharz P et al. (1996) Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38, 543-548.
71. Fell J, Paintin M, Arnaud-Battandier F et al. (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14, 281-289.
72. Yamamoto T, Nakahigashi M, Saniabadi AR et al. (2007) Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: a prospective study. Inflamm Bowel Dis 13, 1493-1501.
73. Verma S, Brown S, Kirkwood B et al. (2000) Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol 95, 735-739.
74. O'Sullivan M & O'Morain C (1998) Nutritional therapy in Crohn's disease. Inflamm Bowel Dis 4, 45-53.
75. Gassull MA, Fernandez-Banares F, Cabre E et al. (2002) Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51, 164-168.
76. Lochs H, Dejong C, Hammarqvist F et al. (2006) ESPEN guidelines on enteral nutrition: Gastroenterology. Clin Nutr 25, 260-274. (Pubitemid 43811680)
77. Konno M, Kobayashi A, Tomomasa T et al. (2006) Guidelines for the treatment of Crohn's disease in children. Pediatr Int 48, 349-352.